Are you a parent or caregiver to a teenager/young adult with Duchenne Muscular Dystrophy?
Research Niall Dennehy Research Niall Dennehy

Are you a parent or caregiver to a teenager/young adult with Duchenne Muscular Dystrophy?

We are doing research to assist us in creating resources for teenagers with Duchenne Muscular Dystrophy to help them prepare for moving into adulthood. What's involved? An individual interview online or in person with Siobhán O'Shea, postgraduate researcher, Discipline of Occupational Therapy, Trinity College Dublin' if you choose to take part.

Read More
Calling adults with Duchenne Muscular Dystrophy to share their experiences of moving into adulthood
Research Niall Dennehy Research Niall Dennehy

Calling adults with Duchenne Muscular Dystrophy to share their experiences of moving into adulthood

We are doing research to assist us in creating resources for teenagers with Duchenne Muscular Dystrophy to help them prepare for moving into adulthood. What's involved? An individual interview online or in person with Siobhán O'Shea, postgraduate researcher, Discipline of Occupational Therapy, Trinity College Dublin' if you choose to take part.

Read More
The Neurological Alliance of Ireland is calling for a dedicated Consultant Neurologist for Bantry hospital
News Niall Dennehy News Niall Dennehy

The Neurological Alliance of Ireland is calling for a dedicated Consultant Neurologist for Bantry hospital

On Tuesday March 26th at 1pm NAI will be holding an online event to enable TDs and counsellors to hear from local patients, patient organisations and clinicians on the need for a dedicated Neurology Service for Bantry hospital. Bantry hospital currently provides some clinics for neurological patients and there is an urgent need to secure and develop a dedicated neurology outpatient service in Bantry for patients throughout West Cork and Kerry.

Read More
Take action now for local neurology services</a>: #patientsdeservebetter
News Niall Dennehy News Niall Dennehy

Take action now for local neurology services: #patientsdeservebetter

The Neurological Alliance of Ireland, the national umbrella for neurological charities, together with 23 of its member organisations is asking people to take action for local neurology services. The Patient Deserve Better campaign is a joint initiative brought to you by NAI and Roche Products (Ireland) Ltd.

Read More
Spotlight on members of our community living with neuromuscular conditions: Tania Quill

Spotlight on members of our community living with neuromuscular conditions: Tania Quill

We began on Rare Disease Day, 29 February, to draw attention to the fact that rare disease isn’t just for one day. By sharing individual stories and information on their conditions, we want to raise awareness about the many neuromuscular conditions experienced by the diverse members of our community to whom MDI offers support.

Read More
Irish Wheelchair Association’s ability programme inviting jobseekers
News Niall Dennehy News Niall Dennehy

Irish Wheelchair Association’s ability programme inviting jobseekers

Providing holistic, person-centred Coaching to enable a person to become an independent jobseeker or employee. Funded by the Dormant Accounts Fund and administered through Pobal, Ability is an employability and job-seeking skills programme for people aged 18 and over with a physical disability who want to get closer to work and progress on their career journey.

Read More
Barretstown and MDI, Youth Camp 2024

Barretstown and MDI, Youth Camp 2024

MDI are delighted to announce an exciting new partnership with Barretstown Children’s Charity to run this years MDI Youth Camp. To celebrate we are working hard to organise a wonderful weekend away from 25th - 26th of May for some of our young members aged between 1 - 17 years old with their immediate families or carers.

Read More
HSE Patient Feedback For National Genetics And Genomics Office
Research Niall Dennehy Research Niall Dennehy

HSE Patient Feedback For National Genetics And Genomics Office

National Genetics & Genomics Office are aiming to better understand what people who are referred to genetic and genomic services, and their families, need to know to help them better navigate services. The knowledge gained will be used to work towards an improved patient experience of using genetic and genomic services. More information the advert attached. Expressions of interest close on 23rd February 2024.

Read More
Inclusivity for Persons With Disabilities? The Electoral Rights of Persons With Disabilities in the European Union
News, Advocacy Niall Dennehy News, Advocacy Niall Dennehy

Inclusivity for Persons With Disabilities? The Electoral Rights of Persons With Disabilities in the European Union

The first instalment in the 2024 Institute of International and European Affairs (IIEA) Disability Policy series will take place this Friday 16 February at 1pm when Dr Alejandro Moledo, Deputy Director of the European Disability Forum, will discuss the ‘The Electoral Rights of Persons with Disabilities in the European Union’ on a webinar.

Read More
Action Duchenne: Winter Webinar – James Poysky
News Niall Dennehy News Niall Dennehy

Action Duchenne: Winter Webinar – James Poysky

As part of Action Duchenne’s: Science Education programme, they will be running a series of Winter Webinars with some of your favourite Duchenne experts! Action Duchenne are delighted to announce that they will be welcoming renowned psychologist and Duchenne expert Dr James Poysky to theiir webinar series.

Read More
EMA confirms recommendation not to renew marketing authorisation for Translarna
Research, News Niall Dennehy Research, News Niall Dennehy

EMA confirms recommendation not to renew marketing authorisation for Translarna

The CHMP agreed to re-examine its decision on request of the manufacturer PTC. This took place in January and despite efforts from the manufacturer and patient community the EMA announced on Friday, 26 January 2024 recommendation for non-renewal of authorisation of Translarna. The process found that while there was evidence of benefit from the treatment, it’s not statistically significant. Importantly there was no concerns about the safety of the treatment.

Read More